Biomarker discovery: Tissues versus fluids versus both

Expert Review of Molecular Diagnostics

Volumn 7, Issue 5, 2007, Pages 473-475

  Johann Jr , Donald J ^b   Blonder, Josip ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

BREAST CANCER; CANCER MORTALITY; CANCER RESEARCH; CANCER SCREENING; CANCER THERAPY; CAUSE OF DEATH; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; GENOMICS; HUMAN; MASS SPECTROMETRY; METABOLOMICS; PATHOPHYSIOLOGY; PROTEOMICS; SENSITIVITY AND SPECIFICITY; BLOOD ANALYSIS; BODY FLUID; CHEMISTRY; METHODOLOGY;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BODY FLUIDS; HUMANS; MASS SPECTROMETRY;

EID: 35148829338     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.7.5.473     Document Type: Editorial

References (9)

1. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971-983 (2006).
2. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. Cancer J. Clin. 57, 90-104 (2007).
3. Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer 2, 6-25 (2007).
4. Petricoin EF, Zoon KC, Kohn EC et al. Clinical proteomics translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 1, 683-695 (2002).
5. Chatterjee SK, Zetter BR. Cancer biomarkers knowing the present and predicting the future. Future Oncol. 1, 37-50 (2005).
6. Kuramitsu Y, Nakamura K. Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers. Proteomics 6, 5650-5661 (2006).
7. Blonder J, Terunuma A, Conrads TP et al. A proteomic characterization of the plasma membrane of human epidermis by high-throughput mass spectrometry. J. Invest. Dermatol. 123, 691-699 (2004).
8. Hood BL, Darfler MM, Guiel TG et al. Proteomic analysis of formalin-fixed prostate cancer tissue. Mol. Cell. Proteomics 4, 1741-1753 (2005).
9. Hwang SI, Thumar J, Lundgren DH et al. Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene 26, 65-76 (2006).